RNS20 May 2021 10:11
Anyone know anything about this chap?
Appointment of Chief Scientific Officer
ReNeuron Group plc (AIM: RENE), a UK-based global leader in the development of cell-based therapeutics, announces the appointment of Dr Stefano Pluchino as Chief Scientific Officer with immediate effect. Dr Pluchino will join the Company on a part-time basis and brings with him a wealth of knowledge of cell and gene therapy.
Dr Stefano Pluchino is Reader in Regenerative Neuroimmunology and Honorary Consultant at the University of Cambridge since 2010. He obtained his MD and PhD at the University of Siena, Italy, and progressed to two consecutive post doctorate appointments at the San Raffaele Scientific Institute in Milan, Italy.
Dr Pluchino has published over 120 peer-reviewed papers, including several in top journals, including Nature, Cell and Cell Stem Cell, and is internationally recognised as a leader and pioneer in the field of regenerative neuroimmunology. He was the recipient of the 2003 European Charcot Foundation (ECF) Award, the 2006 Serono Foundation Multiple Sclerosis Award, the 2007 Rita Levi-Montalcini award, hosted by the Italian Foundation for Multiple Sclerosis, the 2009 Italian Ministry of Health Young Investigator Award and the 2010 International Royan Award for outstanding research in Stem Cell Biology and Technology.
Olav Hellebø, Chief Executive Officer, commented: "We are delighted to welcome Dr Pluchino to ReNeuron. His extensive experience of cell and gene therapy as well as deep knowledge in the exosomes field will be invaluable to us in what is an incredibly exciting and progressive time. Dr Pluchino's work is widely recognised, and we look forward to working alongside him, as ReNeuron continues to grow and develop its pipeline."